| Dr Eric Brendon Jones, OD | |
|
2840 Hwy. 95, Suite #108, Bullhead City, AZ 86442 | |
| (928) 758-2020 | |
| (928) 758-4544 |
| Full Name | Dr Eric Brendon Jones |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 2840 Hwy. 95, Bullhead City, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285694174 | NPI | - | NPPES |
| 1285694174 | Other | AZ | NPI |
| Z114997 | Other | AZ | PTAN |
| Z114980 | Other | AZ | PTAN |
| 1760692768 | Other | AZ | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1499 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Brendon Jones, OD 2840 Hwy. 95, Suite #108, Bullhead City, AZ 86442 Ph: (928) 758-2020 | Dr Eric Brendon Jones, OD 2840 Hwy. 95, Suite #108, Bullhead City, AZ 86442 Ph: (928) 758-2020 |
News Archive
Cara Therapeutics, Inc. today announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center, double-blind, placebo-controlled study was conducted at eight hospitals in the United States and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted hysterectomy.
ChemoCentryx, Inc., today announced that it has undertaken a Phase II clinical trial of CCX140, a novel, orally-available small molecule compound designed to specifically target the chemokine receptor known as CCR2.
What if there was a drug that could completely eliminate airborne disease transmission that occurs when someone coughs. Researchers at the University of Alberta believe they have found a way to achieve this.
The Memory Improvement with Docosahexaenoic acid Study published online this week in Alzheimer's & Dementia: The Journal of the Alzheimer's Association showed that algal DHA improved memory function in healthy aging adults, providing a benefit roughly equivalent to having the learning and memory skills of someone three years younger.
A team of researchers led by Worcester Polytechnic Institute Provost Wole Soboyejo has identified targeted drugs that reduced the sizes of hard-to-treat breast cancer tumors in mice without inducing the toxic side effects that are typically associated with conventional chemotherapy.
› Verified 9 days ago
Clark Eyecare, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 2840 Highway 95, Walmart Vision Center Suite 505, Bullhead City, AZ 86442 Phone: 928-758-1524 Fax: 928-758-1683 | |
Dr. James A. Richardson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2840 Hiway 95, Suite 108, Bullhead City, AZ 86442 Phone: 928-758-2020 Fax: 928-758-4544 | |
Dr. Jennifer Phuong-uyen Nguyen, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2840 Highway 95 Ste 416-418, Bullhead City, AZ 86442 Phone: 928-704-1808 Fax: 928-704-1814 | |
Mohave Eye Center, Ltd Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3003 Highway 95, Suite 11, Bullhead City, AZ 86442 Phone: 928-763-1000 Fax: 928-758-4983 | |
Dr. Christopher N Clark, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2840 Highway 95 Ste 505, Bullhead City, AZ 86442 Phone: 928-758-1450 Fax: 928-758-1683 | |
Colorado River Eye Care, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2840 Hiway 95, Suite 108, Bullhead City, AZ 86442 Phone: 958-758-2020 Fax: 928-758-4544 |